| | | | | |
ANIK Anika Therapeutics Inc | €18,6948 | +0,79% | €254,70M | €75,18K | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | €9,0364 | -0,66% | €254,62M | €345,56 | |
GPAC General Purpose Acquisition Corp. Class A Ordinary Shares | €8,6736 | +0,00% | €254,58M | €4,34K | |
BPRN Princeton Bancorp, Inc. Common Stock (PA) | €37,1477 | +0,56% | €254,44M | €26,66K | |
| €38,9748 | +0,41% | €254,29M | €14,41K | |
ACGC ACP Holdings Acquisition Corp. Class A Ordinary Shares | €8,6554 | +0,19% | €254,29M | €86,40K | |
HCAC Hall Chadwick Acquisition Corp Class A Ordinary Shares | €8,6995 | -0,10% | €254,27M | €164,14 | |
SLN Silence Therapeutics Plc American Depository Share | €12,1637 | -1,88% | €254,22M | €1,28M | |
MTNE CH4 Natural Solutions Corporation | €8,5310 | +0,04% | €253,88M | €124,40 | |
RXST RxSight, Inc. Common Stock | €5,5030 | -1,70% | €253,68M | €615,56K | |
NHIC NewHold Investment Corp III Class A Ordinary shares | €9,1919 | +0,00% | €253,57M | €100,06K | |
IRHO Iron Horse Acquisitions II Corp. Common Stock | €8,6433 | -0,10% | €253,54M | €74,72K | |
CNXU Conexeu Sciences Inc. Common Stock | €8,6390 | +2,25% | €253,35M | €348,91K | |
| €8,6304 | -2,73% | €253,10M | €1,02M | |
JCE Nuveen Core Equity Alpha Fund | €14,7554 | -0,76% | €252,93M | €19,95K | |
